Canada Spends Logo

Explore our Budget 2026 analysis

Grant: CIHR Fellowship

McGill University

$135,000.00

Anti-hypertensive treatment in pregnancy and the risk of acute kidney injury

FY 2013-14

Summary
Approximately 6% of pregnant women have high blood pressure (hypertension) in pregnancy. Hypertension during pregnancy can progress to pre-eclampsia, a severe onset of high blood pressure which can affect multiple organ systems and can cause seizures. Physicians routinely treat women with anti-hypertensive medications to lower their blood pressure. Both Canada and the United Kingdom have advocated for more aggressive treatment of hypertension in pregnancy, which have improved certain aspects of maternal and newborn health; however, the potential for a rare adverse outcome such as acute kidney injury has not been adequately studied. My doctoral thesis found a dramatic increase in the rate of acute kidney injury among women with pre-eclampsia in Canada. Acute kidney injury is a rapid deterioration of the function of the kidneys, the key organ for filtering waste products from the blood and maintaining electrolyte balance. The increase is concerning because acute kidney injury is a serious condition associated with long hospital stays and a high death rate. I aim to find out whether changes in anti-hypertensive treatments explained the recent rise in acute kidney injury. I will analyze de-identified data in Quebec and the United Kingdom, which contain information on doctor and hospital visits and drug prescriptions among pregnant women. This will be the first study to explore this issue in a large database. Findings from this research will help health care providers understand the risks of prescribing anti-hypertensive medication in pregnancy and to make the safest decisions about treating hypertension in pregnancy. Overall, this research will provide evidence which may help improve the health of women and newborns.
Program
CIHR Fellowship
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
301262
Name
Mehrabadi Azar
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Health Services and Policy Research
Theme2
Health systems / services
Prcname2
Health Research Training A - Post-PhD (HTA)
Projecttitle
Anti-hypertensive treatment in pregnancy and the risk of acute kidney injury
Programtype2
Fellowship Programs
Orgnameinp2
McGill University
Cihramount2
$135,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Anti-Hypertensive Medication; Hypertensive Disorders Of Pregnancy; Perinatal Epidemiology; Pharmacoepidemiology; Severe Maternal Morbidity
Abstract
Approximately 6% of pregnant women have high blood pressure (hypertension) in pregnancy. Hypertension during pregnancy can progress to pre-eclampsia, a severe onset of high blood pressure which can affect multiple organ systems and can cause seizures. Physicians routinely treat women with anti-hypertensive medications to lower their blood pressure. Both Canada and the United Kingdom have advocated for more aggressive treatment of hypertension in pregnancy, which have improved certain aspects of maternal and newborn health; however, the potential for a rare adverse outcome such as acute kidney injury has not been adequately studied. My doctoral thesis found a dramatic increase in the rate of acute kidney injury among women with pre-eclampsia in Canada. Acute kidney injury is a rapid deterioration of the function of the kidneys, the key organ for filtering waste products from the blood and maintaining electrolyte balance. The increase is concerning because acute kidney injury is a serious condition associated with long hospital stays and a high death rate. I aim to find out whether changes in anti-hypertensive treatments explained the recent rise in acute kidney injury. I will analyze de-identified data in Quebec and the United Kingdom, which contain information on doctor and hospital visits and drug prescriptions among pregnant women. This will be the first study to explore this issue in a large database. Findings from this research will help health care providers understand the risks of prescribing anti-hypertensive medication in pregnancy and to make the safest decisions about treating hypertension in pregnancy. Overall, this research will provide evidence which may help improve the health of women and newborns.
Competitiondate
201311
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Mehrabadi, Azar
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $135,000~ $0~